Contact
searchSearch
HMP Global
AMP 2026

Long-Term Evidence From DEEPER OUS

Four-Year Outcomes of Retrievable Scaffold Therapy in Conjunction With Drug-Coated Balloons

Marianne Brodmann, MD
08/25/2026

In this video, Marianne Brodmann, MD, from the Medical University of Graz in Austria, discusses one of the presentations she gave at the 2026 Amputation Prevention Symposium on the 4-year results of the DEEPER OUS trial. This trial evaluated the safety and efficacy of the Bare Temporary Spur Stent System (Reflow Medical). 

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.

Related Content

Bioresorbable Scaffolds
Abbott Secures CE Mark for Longer-Length Esprit BTK System for Severe PAD in Europe
08/26/2026
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit...
08/26/2026
Cath Lab Digest
pVasc NET (Vesalio)
Thrombectomy
Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device With Integrated Distal Filter
08/17/2026
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s...
08/17/2026
Cath Lab Digest
Case Report
Revascularizing Femoropopliteal Chronic Total Occlusions With Atheroplasty: A Case-Based Discussion
08/13/2026
Michael Lichtenberg MD; Stefan Stahlhoff, MD
This case illustrates the application of the Santreva-ATK system (AngioSafe) in a complex femoropopliteal CTO.
This case illustrates the application of the Santreva-ATK system (AngioSafe) in a complex femoropopliteal CTO.
This case illustrates the...
08/13/2026
Vascular Disease Management
Review
Safety of Outpatient Endovascular Interventions for Peripheral Arterial Disease: Evidence and Applications for U.S. Practice
08/12/2026
Naina G. Subherwal; Simran P. Subherwal; Sreejit Nair, MD; Ashwani Sastry, MD
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31...
08/12/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

NYU Langone
NYU Langone Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology
08/27/2026
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed...
08/27/2026
Vascular Disease Management
Bioresorbable Scaffolds
Abbott Secures CE Mark for Longer-Length Esprit BTK System for Severe PAD in Europe
08/26/2026
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit...
08/26/2026
Cath Lab Digest
Radiation Safety
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
08/20/2026
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company...
08/20/2026
Cath Lab Digest
Imaging of acute ischemic stroke
Stroke Treatment
Siemens Healthineers Receives ARPA-H Funding of up to $31M to Advance Remote Endovascular Robotics for Acute Stroke Treatment
08/20/2026
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential...
08/20/2026
Cath Lab Digest
Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management
pVasc NET (Vesalio)
Thrombectomy
Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device With Integrated Distal Filter
08/17/2026
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s...
08/17/2026
Cath Lab Digest
JANE-2 project
Green Paper
Tumor Ablation Review Maps Next Phase of Cancer Care
08/14/2026
Laura Simson, MA
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of...
08/14/2026
Vascular Disease Management
Intravascular Lithotripsy
FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero Peripheral IVL System
08/12/2026
The U.S. pivotal study will evaluate FastWave's electric IVL system in patients with peripheral artery disease.
The U.S. pivotal study will evaluate FastWave's electric IVL system in patients with peripheral artery disease.
The U.S. pivotal study will...
08/12/2026
Cath Lab Digest
Embolic Technologies
Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platform
08/12/2026
SALT LAKE CITY, Utah — August 6, 2026 — Fluidx Medical Technology, Inc., a developer of innovative embolic technologies, today announced the successful closing of financing to fund development and growth. The financing follows significant...
SALT LAKE CITY, Utah — August 6, 2026 — Fluidx Medical Technology, Inc., a developer of innovative embolic technologies, today announced the successful closing of financing to fund development and growth. The financing follows significant...
SALT LAKE CITY, Utah — August 6,...
08/12/2026
Vascular Disease Management
Phase 3 Randomized Clinical Trial
TACE Plus Ablation Improves Survival in Unresectable HCC Compared With TACE Alone
08/11/2026
Laura Simson, MA
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency...
08/11/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use